Beyond VEGF: Inhibition of the Fibroblast Growth Factor Pathway and Antiangiogenesis

MLA

Michael J. Overman, et al. “Beyond VEGF: Inhibition of the Fibroblast Growth Factor Pathway and Antiangiogenesis.” Clinical Cancer Research, vol. 17, Oct. 2011, pp. 6130–39. EBSCOhost, https://doi.org/10.1158/1078-0432.ccr-11-0659.

APA

Michael J. Overman, Christopher H. Lieu, Hai T. Tran, Scott Kopetz, & John V. Heymach. (2011). Beyond VEGF: Inhibition of the Fibroblast Growth Factor Pathway and Antiangiogenesis. Clinical Cancer Research, 17, 6130–6139. https://doi.org/10.1158/1078-0432.ccr-11-0659

Chicago

Michael J. Overman, Christopher H. Lieu, Hai T. Tran, Scott Kopetz, and John V. Heymach. 2011. “Beyond VEGF: Inhibition of the Fibroblast Growth Factor Pathway and Antiangiogenesis.” Clinical Cancer Research 17 (October): 6130–39. doi:10.1158/1078-0432.ccr-11-0659.